Get started
MEDPACTO, INC.MEDPACTO, INC.MEDPACTO, INC.

MEDPACTO, INC.

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

235980 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

MedPacto, Inc. researches and develops anti-cancer drugs. It engages in the development of therapeutic products to cure ulcer or neuropathy caused by diabetes. The company was founded by Seong-Jin Kim on June 19, 2013 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

235980 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company